Targeting mutations in bladder cancer related to the ARID1A gene
Targeting ARID1A mutated Urothelial Carcinoma
This study is looking at how changes in the ARID1A gene might affect bladder cancer in older Veterans, especially those who have been exposed to things like smoking, to help find better treatments for those with this gene mutation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Salt Lake City Healthcare System NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10951535 on NIH RePORTER |
What this research studies
This research investigates the role of the ARID1A gene mutation in bladder cancer, particularly in aging Veterans who are at higher risk due to factors like smoking and exposure to carcinogens. The study aims to understand how these mutations contribute to treatment resistance and cancer progression. By focusing on the epigenetic alterations associated with ARID1A, the research seeks to develop targeted therapies that could improve outcomes for patients with this specific mutation. The approach includes characterizing the biological mechanisms behind ARID1A mutations and their impact on cancer stem cell behavior.
Who could benefit from this research
Good fit: Ideal candidates for this research are Veterans diagnosed with bladder cancer, particularly those with ARID1A mutations.
Not a fit: Patients without bladder cancer or those whose tumors do not have ARID1A mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies for bladder cancer patients with ARID1A mutations, potentially improving treatment outcomes and reducing recurrence.
How similar studies have performed: While targeting specific genetic mutations in cancer is a growing field, this particular focus on ARID1A mutations in bladder cancer is relatively novel and has not been extensively tested in prior research.
Where this research is happening
Salt Lake City, United States
- VA Salt Lake City Healthcare System — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Gupta, Sumati — VA Salt Lake City Healthcare System
- Study coordinator: Gupta, Sumati
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.